Literature DB >> 24739030

Diagnostic accuracy of the SNAP and Spec canine pancreatic lipase tests for pancreatitis in dogs presenting with clinical signs of acute abdominal disease.

Mark D Haworth1, Giselle Hosgood, Katrin L Swindells, Caroline S Mansfield.   

Abstract

OBJECTIVES: To (i) assess the clinical diagnostic accuracy of SNAP canine pancreatic lipase (cPL) and specific canine pancreatic lipase (Spec cPL) and (ii) assess the agreement of an abnormal test result between SNAP cPL and Spec cPL in dogs presenting with acute abdominal disease.
DESIGN: Prospective observational cohort study.
SETTING: University teaching hospital emergency center. ANIMALS: Thirty-eight client-owned dogs that presented with acute abdominal disease, with a known final diagnosis between March 2009 and April 2010. Dogs were retrospectively assigned into 2 groups, dogs with acute pancreatitis (AP) (Group 1) and dogs without AP (Group 2).
INTERVENTIONS: Paired serum samples obtained within 24 hours of presentation were analyzed using the SNAP cPL test and Spec cPL assay. MEASUREMENTS AND
RESULTS: SNAP cPL clinical sensitivity and specificity was 82% (9/11 dogs of group 1) and 59% (16/27 dogs of group 2), respectively. Spec cPL clinical sensitivity and specificity was 70% (7/10 dogs of group 1) and 77% (20/26 dogs of group 2), respectively. Accuracy of the SNAP and Spec cPL for a clinical diagnosis of pancreatitis was found to be 66% and 75%, respectively. Agreement between a positive SNAP (cPL ≥ 200 μg/L) and a clinical diagnosis pancreatitis resulted in κ = 0.33. Agreement between an increased Spec (cPL ≥ 400 μg/L) and a clinical diagnosis of pancreatitis resulted in a κ = 0.43. The agreement between SNAP and Spec cPL (cPL ≥ 200 μg/L) for the entire cohort resulted in κ = 0.78.
CONCLUSION: SNAP cPL and Spec cPL results may provide a "false positive" diagnosis of pancreatitis in up to 40% of dogs presenting with acute abdominal disease. There is good overall agreement between SNAP cPL and Spec cPL; however, there were 4/38 dogs with positive SNAP cPL and "normal" Spec cPL. © Veterinary Emergency and Critical Care Society 2014.

Entities:  

Keywords:  acute abdomen; dogs; pancreatic disease; point-of-care diagnostics

Mesh:

Substances:

Year:  2014        PMID: 24739030     DOI: 10.1111/vec.12158

Source DB:  PubMed          Journal:  J Vet Emerg Crit Care (San Antonio)        ISSN: 1476-4431


  20 in total

1.  Suspected acute pancreatitis in a dog following honeybee envenomation.

Authors:  Jennifer Groover; Michael Schaer; Leonel Londoño
Journal:  Can Vet J       Date:  2020-04       Impact factor: 1.008

2.  Risk factors for gastrointestinal upset and evaluation of outcome following surgical resection of canine pancreatic β-cell tumors.

Authors:  Leah P Hixon; Janet A Grimes; Mandy L Wallace; Chad W Schmiedt
Journal:  Can Vet J       Date:  2019-12       Impact factor: 1.008

3.  Letter to the editor.

Authors:  Dianne Mawby; Jacqueline Whittemore; Kellie Fecteau
Journal:  J Vet Intern Med       Date:  2014 Nov-Dec       Impact factor: 3.333

4.  Evaluation of SNAP cPL, Spec cPL, VetScan cPL Rapid Test, and Precision PSL Assays for the Diagnosis of Clinical Pancreatitis in Dogs.

Authors:  H Cridge; A G MacLeod; G E Pachtinger; A J Mackin; A M Sullivant; J M Thomason; T M Archer; K V Lunsford; K Rosenthal; R W Wills
Journal:  J Vet Intern Med       Date:  2018-02-09       Impact factor: 3.333

5.  Assessment of Canine Pancreas-Specific Lipase and Outcomes in Dogs with Hemodialysis-Dependent Acute Kidney Injury.

Authors:  K Takada; C A Palm; S E Epstein; L D Cowgill
Journal:  J Vet Intern Med       Date:  2018-02-22       Impact factor: 3.333

6.  Development and validation of a novel clinical scoring system for short-term prediction of death in dogs with acute pancreatitis.

Authors:  Virginie Fabrès; Olivier Dossin; Clémence Reif; Miguel Campos; Valerie Freiche; Christelle Maurey; Fanny Pilot-Storck; Loïc Desquilbet; Ghita Benchekroun
Journal:  J Vet Intern Med       Date:  2019-02-15       Impact factor: 3.333

7.  Increased canine pancreatic lipase immunoreactivity (cPLI) and 1,2-o-dilauryl-rac-glycero-3-glutaric acid-(6'-methylresorufin) ester (DGGR) lipase in dogs with evidence of portal hypertension and normal pancreatic histology: a pilot study.

Authors:  Gonçalo Serrano; Dominique Paepe; Tim Williams; Penny Watson
Journal:  J Vet Diagn Invest       Date:  2021-04-02       Impact factor: 1.279

8.  Beta-hydroxybutyrate Concentrations in Dogs with Acute Pancreatitis and Without Diabetes Mellitus.

Authors:  F E Hurrell; K J Drobatz; R S Hess
Journal:  J Vet Intern Med       Date:  2016-04-13       Impact factor: 3.333

9.  Validation of a commercial 1,2-o-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester lipase assay for diagnosis of canine pancreatitis.

Authors:  Emily L Goodband; Gonçalo Serrano; Fernando Constantino-Casas; Joy Archer; Penny J Watson; Tim L Williams
Journal:  Vet Rec Open       Date:  2018-05-26

10.  Histopathological findings and canine pancreatic lipase immunoreactivity in normal dogs and dogs with inflammatory and neoplastic diseases of the pancreas.

Authors:  Heike Aupperle-Lellbach; Katrin Törner; Marlies Staudacher; Christina Stadler; Ursula Tress; Julia M Grassinger; Elisabeth Müller; Corinna N Weber
Journal:  J Vet Intern Med       Date:  2020-05-07       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.